SOCIOECONOMIC BENEFITS OF A NURSING-COORDINATED HOME MONITORING OR TELESURVEILLANCE PROGRAM IN PATIENTS ON CARDIAC RESYNCHRONIZATION THERAPY
Section: Artículos Científicos
Authors
Susana Bombín González1, Jerónimo Rubio Sanz2, Lenin René Bulnes García3, María Sandín Fuertes4, Itziar Gómez Salvador5, J. Alberto San Román Calvar6.
Position
1 BSc. Enfermera Instituto de Ciencias del Corazón (ICICOR) del Hospital Clínico Universitario de Valladolid (HCUV). Enfermera responsable del programa de Televigilancia del HCUV.2 PhD. Cardiólogo de la Unidad de Electrofisiología, ICICOR del Hospital Clínico Universitario de Valladolid.3 MD. Doctor Becario ICICOR del Hospital Clínico Universitario de Valladolid.4 PhD. Cardióloga de la Unidad de Electrofisiología, ICICOR del Hospital Clínico Universitario de Valladolid.5 MSc Estadística de la Unidad de Investigación, ICICOR del Hospital Clínico Universitario de Valladolid.6 PhD. Jefe de Servicio de Cardiología del ICICOR del Hospital Clínico Universitario de Valladolid. CIBER of Cardiovascular Diseases (CIBERCV), Madrid.
Contact address
Susana Bombín González. Hospital Clínico Universitario de Valladolid. Av. Ramón y Cajal, 3 47003. Valladolid
Contact email: susana_bombin@hotmail.com
Abstract
Introduction: The advantages that telesurveillance programs offer with respect to face-to-face visits are, on the one hand, avoiding travels, which results in a greater comfort for patients and considerable financial savings, and on the other, relieving face-to-face consultations. Objective: To calculate the travels, their cost and the hours of face-to-face consultation avoided in those patients included in the program.
Methodology: The number of kilometers that patients should have traveled from their provinces to our hospital in case they had been revised in a scheduled face-to-face consultation have been calculated, and the economic savings that this has entailed have been estimated, taking the Captio report of mileage 2015 as a reference. The hours of face-to-face consultation avoided have also been evaluated, considering 20 minutes per consultation and the money saved.
Results: 1,326 face-to-face consultations have been avoided in 376 patients with cardiac resynchronization therapy. A mileage of 140,184 km and 1,692 hours of travel have been avoided in those 376 patients. The three provinces most benefited in the number of consultations avoided had a reduction of 160, 118 and 173 consultations, and the savings generated were 16,480 euros and 784 hours, 5,900 euros and 283 hours and 4,411 euros and 236 hours, respectively. An optimization of resources has been verified, since 442 hours of face-to-face consultations and 182,974 euros have been saved.
Conclusions: The telesurveillance program in the patients of the study has avoided many travels, with important associated economic savings, and has avoided the saturation of face-to-face consultations.
Keywords:
patient comfort; cardiac resynchronization therapy devices; remote consultation; cost savings; early diagnosisarrhythmias
Versión en Español
Título:
Artículo completo no disponible en este idioma / Full article is not available in this language
Bibliography
1. Johnson A. Measuring DM´s net effect is harder than you might think. Managed Care. 2003;12:28-32.
2. País Vasco: transformando el Sistema de Salud 2009-2012. Departamento de Sanidad y consumo. Gobierno Vasco. 2012. Disponible en:
https://www.osakidetza.euskadi.eus/contenidos/.../transformando_sistema_salud.pdf
Consultado el 10 mayo 2017
3. Wagner E. Improving Chronic Illness Care: Translating Evidence into Action. Health Affairs. 2001;6:64-78.
4. Bengoa R. Empantanados. RISAI. 2008;1:1-7.
5. Ramos V. Las TICs en el sector de la salud. Bit. 2007;163:Jun-Jul.
6. Real Decreto-Ley 16/2012, de 20 Abril, de medidas urgentes para garantizar la sostenibilidad del Sistema Nacional de Salud y mejorar la calidad y seguridad de sus prestaciones, Boletin Oficial del Estado 24 de abril: Nº98; SECC.1 Pág: 31278-31312. BOE: Boletin Oficial del Estado [Internet]. Madrid: BOE; 2012; [citado 11 mayo 2017] Disponible en:
(https://www.boe.es/boe/dias/2012/04/24/pdfs/BOE-A-2012-5403.pdf)
7. Estrategia para afrontar el reto de la cronicidad en el País Vasco. Departamento de Sanidad y Consumo. Gobierno Vasco [Internet]. 2010 [citado 11 mayo 2017]. Disponible en:
https://www.osakidetza.euskadi.eus/r85-skorga01/es/.../estrategia_cronicidad.html
8. Tracy MC, Epstein AE, Darbar D, el al. 2012 ACCF/AHA/HRS Focused update of the 2008 Guidelines for Device- Based Therapy of Cardiac Rhythm Abnormalities. A Report of the American College of Cardiology Foundation American Heart Association Task Force on Practice Guidelines. Circulation.2012;126:1784-800.
9. Mabo P, Victor F, Bazin P, et al A randomized trial of long- term remote monitoring of pacemaker recipients (THE COMPAS Trial). Eur Heart J. 2012;33:1105-11.
10. Crossley GH, Boyle A, Vitense H, et al. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol. 2011;57:1181-9.
11. Guédon-Moreau L, Lacroix D, Sadoul N, et al. A randomized study of remote follow-up of implantable cardioverter defibrilators; safety and efficacy report of the ECOST trial. Eur Heart J. 2013;34:605-14.
12. Gerhard Hindricks et al. Influence of Home Monitoring on the clinical management of heart failure patients with impaired left ventricular function (IN TIME) European Society of Cardiology [Internet]. ESC 2013 [citado 11 mayo 2017]. Disponible en: http://www.revespcardiol.org/en/summary-of-the-clinical-studies/articulo/90249552/#bib11
13. Landolina M, Perego GB, Lunati M, et al. Remote monitoring reduces healthcare use and improves quality of care in heart failure patientswith implantable defibrillators: the evolution of management strategies of heart failure patientswith implantable defibrillators (EVOLVO)study. Circulation. 2012;125:2985-92.
14. Varma N, Epstein AE, Irimpen A, et al. Efficacy and Safety of Automatic Remote Monitoring for implantable Cardioverter- desfibrillator Follow- up: The Lumos- T Safely reduces Routine office Device Follow- up (TRUST) trial. Circulation. 2010;122:325-332.
15. Marzegalli M, Lunati M, Landolina M, et al. Remote monitoring of CRT-ICD: The multicenter Italian Carelink evaluation – ease of use, acceptance, and organizational implications. Pacing Clin Electrophysiol. 2008;31:1259-64.
16. Wilkoff BL, Auricchio A, Brugada J, HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular implantable electronic devices (CIEDs): Description of Techniques, Personel, Frecuency and ethical considerations (2008). Heart Rhythm. 2008;5:907-25.
17. Captio: Informe Captio del kilometraje 2015. Revista DGT [Internet]. DGT:2015. [citado 8 mayo 2017]. Disponible en:
http://revista.dgt.es/images/CAPTIO_Informe_del_kilometraje_2015.pdf
18. Via Michelin [Internet]. Via Michelin – Ruta. [citado 8 mayo 2017]. Disponible en: https://www.viamichelin.es/web/Itinerarios
19. Real Decreto-Ley 25/2010, de 17 junio, sobre precios públicos por actos asistenciales y servicios sanitarios prestados por la Gerencia Regional de Salud. Boletín Oficial de Castilla y León.2013; 30 diciembre: Nº249; Pág: 83725. BOE: Boletín Oficial de Castilla y León [Internet]. Valladolid: BOCYL; 2013; [citado 1 marzo 2018] Disponible en: bocyl.jcyl.es/boletines/2013/12/30/pdf/BOCYL-D-30122013-5.pdf
